US Hits Chinese Torsion Springs with Duties to Shield American Makers
Published Date: 10/2/2025
Notice
Summary
The U.S. has found that imports of overhead door counterbalance torsion springs from China are hurting American companies because they’re being sold too cheaply and getting unfair government help. This means extra duties will be applied to these imports to protect U.S. businesses like IDC Group and Iowa Spring Manufacturing. These changes kick in soon, aiming to level the playing field and support local jobs.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
U.S. Industry Found Injured by Chinese Imports
The U.S. International Trade Commission determined on September 30, 2025 that imports of overhead door counterbalance torsion springs from China (HTSUS 7320.20.50) are being sold at less than fair value and subsidized, and that a U.S. industry is materially injured by those imports. The Commerce Department made the findings that the imports were subsidized and sold at less than fair value.
Existing AD/CVD Orders' Remedial Effect Preserved
The Commission found that imports subject to Commerce's affirmative critical circumstances determinations are not likely to seriously undermine the remedial effect of the countervailing and antidumping duty orders on overhead door counterbalance torsion springs from China. This means the Commission expects those remedial orders to remain effective against certain imports from China.
Named U.S. Producers Led the Case
The investigations were initiated after petitions filed by IDC Group, Inc. (Minneapolis, MN), Iowa Spring Manufacturing, Inc. (Adel, IA), and Service Spring Corp. (Maumee, OH). These named U.S. companies sought relief under the Tariff Act and are identified in the record of the investigations.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20752, Certain Hydrodermabrasion Systems and Components Thereof; Notice of Vacatur of the Commission's Final Determination and Mootness of the Investigation by the Federal Circuit Due to Patent Expiration
The U.S. International Trade Commission's investigation into certain hydrodermabrasion systems has been canceled because the key patent expired. This affects companies like HydraFacial and Cartessa, ending any legal battles over these products. The case officially closed in March 2026, so no money penalties or import bans will happen now.
2026-20672, Certain Mobile Electronic Devices and Components Thereof; Institution of Investigation
The U.S. International Trade Commission is launching an investigation into certain mobile electronic devices and their parts because trinamiX Sensing LLC and trinamiX GmbH say some products are using their patented technology without permission. This could lead to orders stopping imports and sales of these devices in the U.S., affecting companies involved and possibly shaking up the market soon. The investigation started after complaints filed in September 2026 and could impact money and product availability.
2026-20609, Oleoresin Paprika From India; Determinations
The U.S. International Trade Commission found that imports of oleoresin paprika from India are hurting American businesses because they’re being sold at unfairly low prices and getting government subsidies. This means U.S. companies like Rezolex, Ltd. Co. get some protection through trade rules starting now. Importers and sellers of this spice should expect changes that could affect prices and supply soon.
2026-20673, Seamless Carbon and Alloy Steel Standard, Line, and Pressure Pipe From Czechia, Russia, South Korea, and Ukraine; Scheduling of Full Five-Year Reviews
The U.S. International Trade Commission is kicking off a full review to decide if special duties on seamless steel pipes from Czechia, Russia, South Korea, and Ukraine should stay or go. This review could impact import costs and the steel market, with decisions expected soon after a possible 90-day extension. Steel makers, importers, and users should keep an eye on this as it could affect prices and supply.
2026-20614, Forged Steel Fittings From India and South Korea; Cancellation of Hearing for Antidumping and Countervailing Duty Reviews
The U.S. International Trade Commission has canceled the public hearing for the review of antidumping and countervailing duties on forged steel fittings from India and South Korea. This change affects companies like Bonney Forge and related unions, who will now answer questions without a formal hearing. The cancellation speeds up the process, with no immediate money changes but keeps the review on track.
2026-20349, Railway Tank Cars and Parts Thereof From Mexico; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Preliminary Phase Investigations
The U.S. is launching investigations to see if cheap railway tank cars and parts from Mexico are hurting American businesses. If these imports are found to be unfairly priced or subsidized, extra duties might be added to protect U.S. makers. The first big decision is due by November 16, 2026, so things are moving fast!
Previous / Next Documents
Previous: 2025-19318, 30-Day Notice Waiver for Continuum of Care Program (CoC Builds); Notice of Waiver
HUD is waiving the usual 30-day wait time for applying to the Continuum of Care Program (CoC Builds) funding opportunity announced on September 5, 2025. This means eligible groups can apply faster and get help sooner to support homeless services. If you’re part of this program, act quickly to grab the funding without the usual delay!
Next: 2025-19335, Adjustment to the Aggregate Production Quota for d-Amphetamine (For Sale) and Methylphenidate (For Sale) for 2025 Pursuant to 21 U.S.C. 826(h)
The DEA is changing how much d-amphetamine and methylphenidate can be made in 2025 to meet medical needs better. This affects drug makers and helps ensure enough medicine is available without waste. The update is happening quickly to stick to legal deadlines, but it doesn’t change prices or when you get your meds.